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Abstract
Objective
In the past decade, an increasing number of studies have examined the eﬃcacy of physical
therapy interventions in people with Huntington disease (HD).
Methods
We performed a mixed-methods systematic review using Joanna Briggs Institute (JBI) meth-
odology and included experimental and observational study designs. The search resulted in 23
quantitative studies and 3 qualitative studies from which we extracted data using JBI stan-
dardized extraction tools. Results of this review suggested that physical therapy interventions
may improve motor impairments and activity limitations in people with HD. Here, we expand
on the review ﬁndings to provide speciﬁc recommendations to guide clinical practice.
Results
We recommend the following speciﬁc physical therapy interventions for people with HD:
aerobic exercise (grade A evidence), alone or in combination with resistance training to im-
prove ﬁtness and motor function, and supervised gait training (grade A evidence) to improve
spatiotemporal features of gait. In addition, there is weak (grade B) evidence that exercise
training improves balance but does not show a reduction in the frequency of falls; inspiratory
and expiratory training improves breathing function and capacity; and training of transfers,
getting up from the ﬂoor, and providing strategies to caregivers for involvement in physical
activity in the midstages of HD may improve performance. There is expert consensus for the
use of positioning devices, seating adaptations, and caregiver training in late stages of HD.
Conclusions
There is strong evidence to support physical therapy interventions to improve ﬁtness, motor
function, and gait in persons with HD.
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This clinical practice guideline provides clinical recom-
mendations for physical therapy interventions and patient-
reported outcomes for individuals with Huntington disease
(HD). The target audience are rehabilitation professionals and
referring physicians providing care to persons with HD. The
recommendations should be interpreted by the clinician in the
context of their speciﬁc clinical practice and the patient’s
impairments, goals, and disease stage, while considering the
potential for harm.
We used the Joanna Briggs Institute (JBI) method for critical
appraisal of research, assignment of evidence to the literature,
and assignment of levels of strength to the recommendation.
The JBI method allows for inclusion of experimental study
designs other than randomized controlled trial, such as obser-
vational study designs, retrospective and prospective cohort
studies, expert consensus, and qualitative studies. The inclusion
of a wide range of study designs (i.e., all levels of evidence) was
critical, given the paucity of randomized controlled trials in-
volving physical therapy in HD. The guideline is organized
according to the level of evidence and the grade of the rec-
ommendation (tables 1 and 2) underpinning action state-
ments. A summary of action statements, a description of each
action statement, and research recommendations are provided.
Each individual article was graded based on the 2011 JBI
criteria to determine the level of evidence of each study design
(table 1)1 and the grade of the recommendation (table 2).2
JBI tools were developed by experts in the ﬁeld, piloted,
reviewed, and then approved by the JBI Scientiﬁc Committee.
Levels 1 and 2 diﬀerentiate stronger from weaker studies using
key questions. The grade represents the overall strength of the
evidence available to support the action statement. Each action
statement is preceded by a letter grade to indicate the strength
of the recommendation, followed by a summary of the sup-
porting evidence. A grade of A could be seen as aligning with
“Strong” recommendations in GRADE, and a grade B could
be seen as aligning with “Weak” or “Conditional” recom-
mendations in GRADE. Action statements preceded by a dash
(–) indicate actions based primarily on expert opinion.
Introduction
In 2009, the Physiotherapy Working Group of the European
Huntington Disease Network (EHDN) developed an evidence-
based Clinical Guidance Document to inform optimal phys-
ical therapy management of people with HD and facilitate
uniformity of care internationally.3 Given the limited evidence
at the time, this document was largely based on expert opinion.
Seven treatment-based classiﬁcations were developed to facili-
tate translation of guidelines into clinical practice. These clas-
siﬁcations provided a framework for management of the range
of impairments and activity limitations across the disease stages.
Since 2012, an increasing number of studies have examined the
feasibility and eﬃcacy of physical therapy interventions to im-
prove physical function, mobility, cognition, mood, and quality
of life in individuals with HD. In 2017, the Guidance Document
was revised to incorporate the new literature within a concise,
user-friendly Clinical Practice Guideline.
Table 1 Levels of evidence
Level Sublevel Description
1: Experimental designs A
B
C
D
Systematic review of randomized controlled trials (RCTs)
Systematic review of RCTs and other study designs
RCT
Pseudo-RCT
2: Quasi-experimental designs A
B
C
D
Systematic review of quasi-experimental designs
Systematic review of quasi-experimental designs and other lower study designs
Quasi-experimental prospectively controlled study
Pretest–posttest or historic/retrospective control group study
3: Observational-analytic designs A
B
C
D
E
Systematic review of comparable cohort studies
Systematic review of comparable cohort and other lower study designs
Cohort study with a control group
Case-control study
Observational study without a control group
4: Observational-descriptive studies A
B
C
D
Systematic review of descriptive studies
Cross-sectional study
Case series
Case study
5: Expert opinion and bench research A
B
C
Systematic review of expert opinion
Expert consensus
Bench research/single expert design
Glossary
EHDN = European Huntington Disease Network; HD = Huntington disease; HSG = Huntington Study Group.
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Individuals with HD develop physical, cognitive, and psy-
chological impairments that negatively aﬀect their mobility
and participation in life activities and that ultimately reduce
quality of life.4 Cognitive and psychological impairments
manifest early in the disease. Mobility is negatively aﬀected
by key impairments of chorea, dystonia, and bradykinesia
somewhat later.3,4 Physical therapy encompasses a multi-
tude of interventions ranging from exercise and physical
activity promotion for people to gait and balance training
and ultimately respiratory and palliative care as the disease
progresses. A treatment-based classiﬁcation, which is orga-
nized around impairments and activity limitations across
disease stages, provides a framework for the current guide-
lines. As such, these guidelines encompass a range of phys-
ical therapy outcomes (gait, balance, and quality of life) and
a range of physical therapy interventions (exercise, physical
activity, balance and task-speciﬁc training, and respiratory
training). Given the paucity of evidence available for any
speciﬁc physical therapy intervention on any speciﬁc out-
come, we believe that this approach is most pragmatic and
will yield optimal beneﬁt of providing guidelines to support
evidence-based physical therapy intervention in people
with HD.
A systematic review of the literature to determine that evi-
dence exists to support exercise and physical therapy as
a means to address impairments and activity limitations
present in HD informed these guidelines.5 Of 20 articles that
met the inclusion criteria, the evidence provided preliminary
support for physical therapy interventions for improving
motor function, gait speed, balance, and a range of physical
and social patient-reported outcomes. The authors discussed
the results in terms of application to 7 treatment-based
classiﬁcations to assist physical therapy treatment planning
in HD.6,7
The guideline is designed to answer the following PICO
question: for individuals with HD (all stages) across practice
settings, what is the eﬀect of physical therapy interventions
(e.g., exercise, physical activity interventions, task-speciﬁc
training, gait and balance training, and respiratory training) on
outcomes of mobility, balance, physical ﬁtness, physical ac-
tivity, respiratory function, and patient-reported outcomes
compared with no intervention, wait list control, or social
contact control?
Statement of intent
The target users of this guideline are physical therapists and
physical therapist assistants. Other rehabilitation and referring
physicians may also use these guidelines to support their
practice or referral to physical therapy. It is not intended to
serve as a legal standard of care. This guideline is a summary of
practice recommendations supported by the current pub-
lished literature reviewed by expert clinicians and stake-
holders. Thus, the recommendations set forth herein should
be considered guidelines only, not required directives. Ad-
herence to these recommendations will not ensure a success-
ful outcome in every patient. Clinical judgment on the part of
the rehabilitation professional is critical for determining the
treatment plan for the individual patient, accounting for
clinical data collected from the patient, patient preferences
and values, and clinician expertise and scope of practice.
Methods
In 2016, members of the Guideline Development Group were
tasked by the Huntington Study Group (HSG) and the
EHDN with the development of a clinical guideline for
physical therapy in HD. Funding for this work was received
from the Griﬃn Foundation, HSG, and EHDN. The work-
group solicited members to form a multidisciplinary (neu-
rology, physical therapy, and occupational therapy) advisory
board of people actively involved in management of persons
with HD. The advisory board was involved with the de-
velopment of the content and scope of the guideline.
External review process by stakeholders
External stakeholders were consulted throughout the process
of guideline development so that views and preferences could
be incorporated into the results and discussion sections.
Relevant stakeholders included persons with HD and their
families, physical therapists, speech therapists, neurologists,
psychologists, nurses, and HD researchers.
The stakeholders reviewed the draft of the guideline that was
released for public comment. Ninety-ﬁve percent (22/23) of
patient and family stakeholders felt that the guideline was
deﬁnitely informative, and 100% felt that the guideline would
“deﬁnitely” or “probably” be a useful resource to a physical
therapist or other health care professional. In addition, 100%
Table 2 Grades of recommendations
Grade Recommendation Strength of recommendation
A Strong It is clear that the desirable effects outweigh the undesirable effects
There is evidence of adequate quality supporting the use of the strategy
There is a benefit or no impact on resource use
Values, preferences, and the patient have been taken into account
B Weak Desirable effects appear to outweigh the undesirable effects, but it is not clear
There is evidence supporting the use of the strategy, although it may not be of high quality
There is a benefit, no impact, or minimal impact on resource use
Values, preferences, and the patient may or may not have been taken into account
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endorsed that the guideline provided a better understanding
of the speciﬁc recommendations for exercise and physical
therapy in HD and of the role of exercise for persons withHD.
Comments were solicited from the public via email to pro-
fessional organizations and posting the complete draft of the
clinical practice guideline on the Institute of Knowledge
Translation web site in February 2019. The guideline was
viewed 384 times with 277 downloads. This call included
solicitation for feedback from consumers; applicable com-
ments have been incorporated into the ﬁnal version of the
guideline. A complete draft of the guideline was reviewed by
the American Academy of Neurology Board of Directors in
December 2018 and aﬃrmed the value of this guideline as an
educational tool for neurologists.
Literature search
The protocol for the systematic review has been published8
and was developed using the guidelines set forth by the JBI.9
JBI tools are widely used, with more than 70 collaborating
entities across 34 countries.10 The JBI tools are recognized as
the most congruent for evaluating qualitative studies (Hannes
2010). The initial search included publications between Jan-
uary 2003 and May 2016. An updated search was performed
to inform this clinical practice guideline from May 2016 to
August 2018.
A research librarian from The Ohio State University (L.H.)
conducted searches on the following databases: CINAHL,
PEDro, MEDLINE via PubMed, Cochrane Library, Scopus,
SPORTDiscus, and PsychINFO. The PICO question was
framed as, “Are physical therapy interventions (i.e., exercise,
physical activity interventions, and task-speciﬁc training) rec-
ommended for individuals with HD to improve mobility, bal-
ance, physical activity and patient-related outcomes across
disease stages and practice settings?” The primary keywords
used in the searches were: huntington* disease, physical therap*,
physical activit*, exercise, and physiotherapy*. Additional text
words included the speciﬁc forms of exercise and mobility in-
tervention (see published systematic review5).
The initial search yielded 2,377 records that ultimately resulted
in 18 quantitative articles and 2 qualitative included articles11–30;
a ﬂowchart is available in our published systematic review.5 The
updated search included 5 additional quantitative articles31–35
and 1 additional qualitative article,36 resulting in a total of 23
quantitative and 3 qualitative studies reviewed. A table sum-
marizing all quantitative studies is publicly available on aan.
com/guidelines.
Included articles were those in adults with HD across stages
and care settings that evaluated physical therapy interventions
such as aerobic exercise, strengthening exercise, walking train-
ing, balance training, task-speciﬁc training, seating and posi-
tioning, postural alignment or respiratory interventions, and
included outcomes measuring physical or cognitive function.
For qualitative studies, those that examined perceptions of
physical therapy for the patient, family, or caregiver using
qualitative methods were included. Additional details on in-
clusion and exclusion criteria may be found in our published
systematic review.5
Critical appraisal process
Data were extracted from the studies using the standardized
JBI data extraction tools.9,37 Next, 2 authors within the
guideline development group, who had been trained to use
the JBI tools, independently assessed the methodologic val-
idity before inclusion in the study, followed by verbal dis-
cussion in a group setting to resolve disagreements.
For areas where there was limited or no evidence from the
literature available to guide treatment, we solicited expert
opinion. A custom survey was developed to determine current
treatment practices around the world for seating, secondary
postural changes, and late-stage care. Respondents were asked
to provide a description of speciﬁc interventions used with
individuals with HD for each of these categories. The survey
was distributed to members of the HSG, HD Centers of Ex-
cellence, Degenerative Disease Special Interest Group of the
Academy of Neurologic Physical Therapy of the American
Physical Therapy Association, and the Physiotherapy Work-
ing Group of the EHDN. The responses were pooled to de-
termine consensus expert opinions for areas with limited
evidence. Finally, the results were summarized in narrative
format.
One hundred two individual respondents completed the
survey. Of those, 74% were physical therapists, and 61% had
treated individuals with HD for more than 5 years. Sixty-six
percent of the respondents were from the United States, 21%
from Europe, representing 10 countries, and the remainder
from Canada, Australia, Israel, and New Zealand. Forty-four
percent endorsed working with individuals with HD in the
late stage of the disease; respondents endorsed the following
strategies with individuals with HD with end-stage disease:
positioning, range of motion exercises, active movement, re-
spiratory exercises, and education (ﬁgure 1). These recom-
mendations are summarized as level 5B evidence in table 3.
Data availability
All data are published within this article and associated tables,
ﬁgures, and supplemental data.
Action statements
Action statements are listed ﬁrst with the grade of the rec-
ommendation followed by the recommendation. A stan-
dardized proﬁle of information for each action statement is
available at aan.com/guidelines. A summary of the action
statements, grades of recommendation, and research recom-
mendations is found in table 4. These 2019 guidelines are
based on the literature published between January 2003 and
August 2018. These guidelines will be considered for review in
2024 or sooner if new evidence becomes available. Any
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updates to the guideline in the interim period will be noted on
the American Academy of Neurology web site: aan.com/
guidelines.
Action statement 1: Effectiveness of aerobic
exercisepairedwith strengtheningexercises in
persons with HD
Physical therapists should prescribe aerobic exercise (mod-
erate intensity, 55%–90% heart rate maximum) paired with
upper and lower body strengthening 3 times per week for
a minimum of 12 weeks to improve ﬁtness and to stabilize or
improve motor function (evidence quality: 1–3; recommen-
dation strength: strong).
Supporting evidence and
clinical interpretation
Eight publications12,15,16,19,27,29,31,32 evaluated the impact of
exercise (aerobic, strengthening, and general conditioning)
and/or physical activity interventions to address a range
of outcomes from 6 separate studies. Two pairs of
publications12,15,16,29 included data from the same data set
but evaluated diﬀerent outcomes. Intervention durations were
8 weeks,19 12 weeks,12,16,27 14 weeks,32 26 weeks,31 and
9 months.15,29 Frequency of exercise ranged from 3 to 4 times
per week, which included center-based and home-based
exercises.
Four of the 6 studies included aerobic exercise as a component
of the intervention.12,15,16,27,29,31 Exercise intensity varied from
55% to 90% VO2 max (based on actual VO2 max or age-
predicted values), and duration ranged from 10 to 30 minutes
(median duration = 25 minutes). Four studies incorporated
strengthening and general conditioning exercises, involving
core, upper body, and lower body musculature.12,15,16,19,27,29
Four studies12,16,19,32 used a progressive home walking pro-
gram (average once per week). Two studies20,32 incorporated
use of an exercise DVD speciﬁc to persons with HD that in-
cluded balance and circuit training, strengthening, ﬂexibility,
and relaxation exercises.
Action statement 2: Effectiveness of gait training in
persons with HD
Physical therapists should prescribe one-on-one supervised
gait training to improve spatiotemporal measures of gait (e.g.,
walking speed and step length) (evidence quality: 1–4; rec-
ommendation strength: strong).
Supporting evidence and
clinical interpretation
Fourteen studies examined the eﬀects of exercise programs
on clinical and mobility measures. Six randomized con-
trolled trials (level 1C) examined the use of exercise in
outpatient, home, and gym settings to improve mobility. All
studies provided individual supervision, and transportation
was provided for the one gym-based study. Interventions to
improve mobility included gait and transfer training,26
stationary cycling with a home walking program and re-
sistance exercise,12 use of a dance-based video game,21
home exercise with a DVD and a walking program,19 a gym-
based exercise program including aerobic and resistance
Figure 1 A global survey of health care providers with expertise in the treatment of individuals with late-stage HD yielded
the prevalence of physical therapy interventions used
Of the 102 survey respondents, 45
endorsed working with individuals
with late-stage HD. Of those, 82.2%
endorsed the use of positioning,
71.1% used ROM exercise, 73.3%
used active movement, 48.9% in-
cluded respiratory exercises, 88.9%
incorporated education to support
patients, medical staff, and care-
givers, 35.6% reported using addi-
tional interventions for late-stage
care, and only 2.2% of respondents
(i.e., 1 respondent) did not use any
of these strategies. HD = Hunting-
ton disease; ROM = range of
motion.
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exercise,27 and an outpatient-based multidisciplinary in-
tervention of supervised aerobic and resistance training.35
Gait speed (measured with the 10-meter walk test
[10MWT]) improved after use of a DVD for home exercise
and a walking program delivered 3 times a week over 8
weeks19 and following 36 weeks of gait and resistance
training.35 Gait speed did not improve in the home-based,
task-speciﬁc exercise program, but all participant-directed
gait-related goals were met.26 The gym-based aerobic and
resistance training program, a feasibility study, and dance-
based video game play, which did not incorporate walking
training, did not improve gait speed.21,27 The gym-based
therapy was completed by 82% of participants, but only 7 of
the clients achieved the expected 150 minutes of moderate
exercise per week.27 The dance-based video game led to
a decrease in double support percent of gait cycle during
forward and backward walking.21 Mobility measures that
did not demonstrate signiﬁcant improvement in any study
were the 30-second chair stand test,12 step time, and step
time coeﬃcient of variation.19,21
Table 3 Summary of clinical evidence
Category and description of primary movement
impairments
Available
levels of
evidence
Summary of evidence (includes primary
interventions and outcomes)
Exercise capacity and/or physical activity
Absence of or limited motor impairment in functional activities;
potential for cognitive and/or behavioral issues. Focus is on
prevention of future movement system impairments
1C12,19,27,31,32
1D29
2D15
3E16
Primary interventions: aerobic exercise (55%–90% age-predicted
heart rate maximum) and resistance exercise (upper and lower
body, core) 3–4 times per week (minimum of 12 weeks for fitness
and motor function benefits); home-based exercise and walking
programs
Setting: home, outpatient
Primary outcomes: motor function (UHDRS total motor or modified
motor), fitness (VO2 max)
Secondary outcomes: physical performance test, six-minute walk
test, Lorig Self-Efficacy for Exercise, physical activity (measured by
pedometers or the International Physical Activity Questionnaire),
Berg Balance Scale, gait speed, quality of life, and cognitive tests.
Mobility and function
Impairments in strength or fatigue resulting in mobility
limitations; slow gait
1C12,19,21,26,27,35
2D11,13,23–25,30
3E22,34
4C14
Primary interventions: task-specific training of walking and
transfers; multidisciplinary rehabilitation
Setting: inpatient, outpatient, home, supervised at gym
Primary outcomes: gait speed, Timed Up and Go, spatiotemporal
measures of gait, and ten-meter walk test
Secondary outcomes: balance (Romberg, Berg Balance Scale,
functional reach test, Pastor test, and four square step test) and
balance confidence (ABC Scale)
Balance and falls risk
Impairments in balance; increased falls risk
1C12,21,26,29
2D11,23–25
4C14,33
Primary interventions: task-specific training of balance;
multidisciplinary rehabilitation
Setting: outpatient clinic, inpatient rehabilitation hospital,
community, and home settings
Primary outcomes: none
Secondary outcomes: balance (Romberg, Berg Balance Scale,
functional reach test, Pastor test, and four square step test), balance
confidence (ABC Scale); Goal Attainment Scaling
Respiratory function
Impaired respiratory function and capacity, limited endurance,
and/or airway clearance, resulting in restrictions in functional
activities and risk for infection
1C28
1D18
5B Consensus
of expert
opinion survey
Primary interventions: inspiratory and expiratory training, with and
without resistance.
Setting: home
Primary outcomes: respiratorymuscle strength, cough effectiveness
Secondary outcomes: swallowing, breathlessness, exercise capacity/
endurance
Secondary musculoskeletal and postural changes
Musculoskeletal and/or respiratory changes resulting in physical
deconditioning and subsequent decreased participation in daily
living activities or social/work environments.
Altered alignment in sitting or standing due to secondary
adaptive changes, involuntary movements, muscle weakness,
and incoordination resulting in limitations in functional activities
in sitting or standing
2D11,13
5B Consensus
of expert
opinion survey
Primary interventions: transfer training, postural stability training
Setting: outpatient, inpatient rehabilitation
Primary outcomes: gait (double support %, stride length, and gait
speed), force plate (length and speed of center of mass projection),
physical performance test, and Tinetti mobility test
Secondary outcomes: Berg Balance Scale, Timed Up and Go, Barthel
Index, and UHDRS Total Functional Capacity Scale
End stage
Active or passive range of motion limitations and poor active
movement control resulting in inability to ambulate; dependent
for most ADLs; difficulty maintaining upright sitting posture
5B Consensus
of expert
opinion survey
Primary interventions: multisensory stimulation, hydrotherapy, and
video-based exercise
Setting: home, specialized unit for late-stage HD
Primary outcomes: behavior Mood Disturbance Scale; quality of life
measures
Secondary outcomes: blood pressure, heart rate, and respiratory
rate
Abbreviations: ABC = Activities-specific Balance Confidence; HD = Huntington disease; UHDRS = Unified Huntington’s Disease Rating Scale; VO2 = volume of
oxygen consumption.
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There were 6 pre/post-test control group studies addressing
mobility and functional activities (level 2D). Four of these
studies provided the intervention as part of an inpatient
multidisciplinary program.13,24,25,30 Clients were admitted for
3 weeks (intervention administered for 8 hours per day, 7 days
a week) either once or 3 times per year. Studies that asked
clients to return 3 times per year had higher dropout rates,
with 60%–83% completing the intervention over 1–2
years.24,25,30 Mobility improved as measured by gait speed,
Timed Up and Go (TUG) test,24,25 Tinetti performance
oriented mobility assessment,13,30 and the physical perfor-
mance test13 when assessed over a 1-year period. When the
intervention was extended over 2 years, mobility (i.e., gait
speed and TUG performance) did not decline.25 All studies
administered multidisciplinary intervention; given the design
and quality of the studies, it is diﬃcult to conclude that
physical therapy or any speciﬁc physical therapy intervention
led to the improvements in mobility.
Two studies (level 2D) examined the impact of outpatient
physical therapy on gait.11,23 Mirek et al.23 provided a pro-
prioceptive neuromuscular facilitation-based intervention fo-
cused on gait and balance 3 times a week, 90 minutes per
session. After 3 weeks, there was signiﬁcant improvement in gait
speed (measured by 10MWT) and mobility (measured by
TUG and Tinetti Mobility Test). Bohlen et al.11 reported sig-
niﬁcant changes in spatiotemporal parameters of gait, gait speed,
and TUG time following one-on-one physical therapy focused
on gait and transfer training performed 2 times a week, 60
minutes a session for 6 weeks, as well as excellent adherence
with overall attendance of 90% for physical therapy sessions.
These studies support the eﬀectiveness of one-on-one physical
Table 4 Summary of action statements and research recommendations
Action statement
Grade of
recommendation Research recommendations
Effectiveness of aerobic exercise paired with strengthening
exercises in persons with Huntington disease: physical
therapists should prescribe aerobic exercise (moderate
intensity, 55%–90% heart rate maximum) paired with upper
and lower body strengthening 3 times per week for
aminimumof 12weeks to improve fitness and to stabilize or
improve motor function.
A Researchers should conduct larger-scale clinical trials to
determine the efficacy of aerobic and strengthening intervention
on motor function and disease progression. In addition, studies
should address optimal frequency, intensity, and timing of
interventions.
Effectiveness of gait training in persons with Huntington
disease: physical therapists should prescribe one-on-one
supervised gait training to improve spatiotemporal
measures of gait.
A Researchers should conduct larger-scale clinical trials to
determine the efficacy of different gait training interventions
(overground, treadmill, and other) on gait kinematics and kinetics
across stages of the disease. In addition, studies should address
optimal frequency, intensity, and timing of interventions.
Effectiveness of balance exercises in persons with
Huntington disease: physical therapists may prescribe
individualized exercises, including balance exercises,
delivered at amoderate frequency and intensity to improve
balance and balance confidence.
B Researchers should conduct larger-scale clinical trials that use
interventions specifically focused on balance to confirm the
benefits of balance training in persons with HD. Ideally, these
studies should include persons with HD at all stages of the
disease and be of sufficient duration to determine whether
balance interventions will delay onset or decrease numbers of
falls.
Effectiveness of breathing exercises in persons with
Huntingtondisease: physical therapistsmayprovide regular
breathing exercises, including inspiratory and expiratory
training, to improve respiratory muscle strength and cough
effectiveness.
B Researchers should conduct larger-scale clinical trials to confirm
the benefits of respiratory training in persons with HD. Inclusion
of functional testing to determine benefits on functional
performance and/or participation would be useful.
Effectiveness of postural control training in persons with
Huntington disease: physical therapists may prescribe an
individually tailored program to improve postural control
and may use positioning devices to optimize posture.
No
Recommendation
Researchers should conduct larger-scale clinical trials to examine
the effectiveness of postural control exercises in prevention of
secondary postural changes. In addition, studies are needed to
examine the effectiveness of positioning devices in improving
posture, activities of daily living, and reducing caregiver burden in
the advance stage of HD.
Role of physical therapy on ADL’s, seating and positioning in
end-stage care of persons with Huntington disease: physical
therapists should ensure that care plans for individualswith
HD with end-stage disease include appropriate positioning
and seating, active movement, position, respiratory
exercise, and education. Family and caregiver training to
provide strategies for maintaining appropriate ongoing
activity and participation for as long as possible is an
important focus for the physical therapy team as part of
end-stage care.
No
recommendation
Researchers should conduct longitudinal evaluations of end-
stage care in HD. Qualitative and mixed-methods approaches
may be useful, given that there is a consensus-based best
practice standard. Evaluations of end-stage outcomemay also be
informed by long-term cohort studies in which the impact of
lifestyle choices (such as participation in regular physical activity)
is assessed.
Abbreviations: HD = Huntington disease; JBI = Joanna Briggs Institute.
To determine the level of evidence and the grade of recommendation of included studies, we used the JBI Levels of Evidence1 and JBI Grades of
Recommendation.2
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therapy focused on gait training to improve mobility. However,
the ﬁndings are interpreted with caution, as both studies lacked
adequate control groups.
The use of a rollator walker to improve gait parameters is
supported by one single-session observational study without
a control group (level 3E).22 Three weeks of gait training and
seated exercises resulted in improvements in gait speed in
a hospital-based study with no control group (level 3E).34
Finally, there is 1 case series (level 4C), examining the use of
an outpatient group program to improve mobility.14 Three
individuals (2 manifest and 1 premanifest) participated once
a week in a 60-minute group program. A circuit training de-
sign was used with each exercise individualized to the client’s
skill level. All 3 individuals improved gait speed on the 10
MWT and TUG. These 2 studies provide insight into the
potential beneﬁts of individualized circuit training and sup-
port the need for future research in these areas.
Action statement 3: Effectiveness of balance exercises
in persons with HD
Physical therapists may prescribe individualized exercises, in-
cluding balance exercises, delivered at a moderate frequency
and intensity to improve balance and balance conﬁdence (ev-
idence quality: 1, 2, and 4; recommendation strength: weak).
Supporting evidence and
clinical interpretation
Ten studies11,12,14,21,23–26,29,33 examined the eﬀects of exer-
cise programs on clinical balance measures or balance conﬁ-
dence. Four of the 10 studies are classiﬁed as level 1C, 4 as
level 2D, and 2 as level 4C (table 3). Across the 10 studies, the
most commonly used clinical balance outcome was the Berg
Balance Scale (n = 7), followed by the Activities-speciﬁc
Balance Conﬁdence Scale (n = 4), Romberg test (n = 1),
Functional Reach Test (n = 1), Pastor test (n = 1), and the
four square step test (n = 1).
Intervention durations were 3 weeks,23 6 weeks,11,21 8
weeks,14,26,33 9 weeks (3 weeks at 3 times a year for 12
months),24 12 weeks,12 18 weeks (3 weeks at 3 times a year for
24 months),25 and 9 months.29 The frequency of exercise
ranged from 1 to 5 days per week performed in a variety of
settings (outpatient clinic, inpatient rehabilitation hospital,
community, and home).
Six of the 8 studies11,14,23–25,33 included balance-related inter-
ventions such as mobility and skills training (i.e., sit-to-stand
transfers, walking over soft surfaces, reaching, stair-climbing,
and turning), progressive static and dynamic standing balance
exercises (that is, narrowed and altered base of support, forward
and side lunges, standing with eyes open and closed, standing
without arm support, and balance reaction training. Four
studies used aerobic and/or strengthening exercises.12,24,25,29
One study used task-speciﬁc training focused onwalking, sit-to-
stand transfers, and standing.26 One study21 used supervised
playing of the video game Dance Dance Revolution.
Action statement 4: Effectiveness of breathing
exercises in persons with HD
Physical therapists may provide breathing exercises, including
inspiratory and expiratory training, to improve respiratory
muscle strength and cough eﬀectiveness (evidence quality:
1C-D; 5B; recommendation strength: weak).
Supporting evidence and
clinical interpretation
There is grade B evidence to support the use of respiratory
training to improve respiratory function in persons with HD.
In a randomized controlled trial, Reyes et al.28 demonstrated
that 4 months of progressive resistive inspiratory and expi-
ratory training resulted in improved maximal inspiratory and
expiratory pressures, as well as forced vital capacity and peak
expiratory ﬂow when compared with the control group, who
completed ﬁxed-resistance training.
In a pseudo-randomized controlled trial, Jones et al.18 produced
similar ﬁndings, showing that 6 weeks of resisted inspiratory
exercise resulted in improved sniﬀ nasal inspiratory pressure and
peak cough ﬂow. The control group, who performed breathing
exercises without resistance, also demonstrated improvements,
suggesting that regular breathing exercises could improve pul-
monary function in persons with HD.
The expert opinion survey (level 5B) conﬁrmed the results of
these studies; 48.9% of clinicians treating individuals in the
late-stage of HD reported use of respiratory exercises and
speciﬁcally mentioned that their interventions included
breathing exercises and use of an incentive spirometer. Many
clinicians also reported interventions focused on posture and
positioning for improved breathing, family and caregiver ed-
ucation on breathing exercises and chest clearance techniques,
education on breathing techniques such as diaphragmatic and
pursed-lip breathing, and collaboration with respiratory
therapy and speech therapy.
Action statement 5: Effectiveness of postural control
training in persons with HD
Physical therapists may prescribe an individually tailored
program to improve postural control and may use positioning
devices to optimize posture (evidence quality: 2D; recom-
mendation strength: weak).
Supporting evidence and
clinical interpretation
There are 2 pretest-posttest (level 2D) studies,11,13 neither of
which had a control group, to support physical therapy for
secondary musculoskeletal and postural changes in people
with HD.
Training of postural control and stability over 12 sessions in
an outpatient setting did not result in improvement in length
and speed of center of mass projection, as measured by a for-
ce plate.11 In contrast, intensive inpatient multidisciplinary in-
tervention (4 hours per day for 6 days a week), including
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exercises for postural alignment and stability, improved scores
on the Tinetti Mobility Test.13 However, improvement in
Tinetti scores could have been due to the cumulative eﬀects of
the multifactorial nature of the intervention, rather than the
speciﬁc eﬀect of postural alignment and stability training. Future
work needs to examine the speciﬁc eﬀect of postural training.
The consensus among experts was that intervention for sec-
ondary musculoskeletal and postural changes should be tai-
lored to the stage of the disease. For instance, early in the
disease focus can be on active exercises to improve core sta-
bility, muscle strengthening, fall prevention, functional exer-
cises such as sit to stand, getting up from the ﬂoor, and posture
correction. In the later stages of the disease, the focus of in-
tervention shifts to practice of bed mobility, transfer training,
and getting in and out of bed. A second major theme among
experts was the use of positioning devices and supports to
promote better posture and prevent secondarymusculoskeletal
changes. Examples of supports include wedge cushions, bol-
sters, pillows and bed railings for positioning in bed, and
cushions or pillows for positioning in a wheelchair and the use
of safety belt to prevent sliding. In the later stages of the disease,
experts recommended use of specialized wheelchairs such as
the Broda chair (Broda Seating, Chesterﬁeld, MO) for optimal
positioning (including ﬂexible seat-back angle, supported
footrest, pelvic belt, and antitipping devices for safety). Con-
sensus also included educating caregivers on the use and op-
eration of positioning devices and wheelchairs, as well as proper
body mechanics for safe transfer of patients. Additional inter-
ventions that are used frequently but have not been formally
investigated include stretching for contracture management
and prevention, range of motion exercise, and speciﬁc posi-
tioning to encourage feeding and swallowing.
Action statement 6: Role of physical therapy on ADL’s,
seating and positioning in late-stage care of persons
with HD
Physical therapists should ensure that care plans for individuals
withHDwith late-stage disease include appropriate positioning
and seating, active movement, position, respiratory exercise,
and education. Family and caregiver training to provide strat-
egies for maintaining appropriate ongoing activity and partici-
pation for as long as possible is an important focus for the
physical therapy team as part of late-stage care (evidence
quality 5B, recommendation strength: expert opinion).
Supporting evidence and
clinical interpretation
A literature search only revealed review or commentary articles
that describe the application of best practice for late-stage care
in other long-term conditions, and we recommend application
of these principles inHD. Tarolli et al.38 describe their own care
practices through 5 illustrative case examples related to HD,
caregiver burden, advance care planning, and end of life care.
They conclude that it is critical for the multidisciplinary team to
establish realistic goals and expectations and maintain a com-
mitment to patient care preferences and quality of life.
In terms of nursing and rehabilitation care,39 tailored exercise
programs and ongoing active engagement in goal-directed
and social activities are critical to promote mood, motor
function, and quality of life for as long as possible. Supporting
evidence for these recommendations is summarized in Mos-
kowitz and Rao,39 but is limited to 1 randomized trial of
multisensory stimulation in late-stage HD,40 2 single-case
studies41,42 on the role of hydrotherapy for advanced HD and
a 14-week video-based exercise program, and 2 articles
detailing social and gardening activities in inpatient settings.
Recommendations for late-stage care in HD focus on sup-
porting activities of daily living, optimizing attention, posture,
positioning, and seating, particularly during meal and post-
meal times. In addition, there is focus on prevention of falls,
analysis of previous falls, and development of midfall strate-
gies to minimize injury risk. Experts speciﬁcally mentioned
environmental modiﬁcations and seating adaptations to
maximize posture and positioning. Additional treatments that
are used frequently but have not been formally investigated
include prevention of decubiti and airway clearance.
The expert opinion survey conﬁrmed that identiﬁed in the
review and expert commentary. Therapists reported that their
focus was on facilitation of ongoing participation in activities
that were achievable for the person with HD. An important
element was family and caregiver training tomaintain ongoing
activity for as long as possible. Postural adaptations, posi-
tioning range of motion activities, and seating advice were
regular recommendations. The importance of providing
caregivers with strategies to encourage activity was high-
lighted. Last, the risk beneﬁt balance of falls vs inactivity was
pointed out by several experts.
Limitations of recommendations
There are several limitations to this guideline. The recom-
mendations provided in this guideline are based on a small
number of available studies, some of which lack control groups
or use multidisciplinary interventions that limit our ability to
interpret intervention eﬀects. The studies have been graded by
their level of evidence (table 3) to highlight these limitations.
The heterogeneity of disease levels and stages across studies
aﬀects our ability to determine outcomes across disease stages.
Finally, studies in languages other than English were not cap-
tured in our previously published review5 or this guideline; this
could introduce language bias with respect to our results. To
address this issue, we have gathered feedback from a wide range
of professionals to provide a globally relevant guideline.
Guideline implementation
recommendations
Many studies included in this review considered patient
experiences, yielding important insights into how physical
therapy interventions should be implemented in persons with
HD. Qualitative analyses suggest that individuals with HD,
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their caregivers, and therapists perceive exercise as beneﬁcial.
The perceived beneﬁts included physical beneﬁts, such as
improved gait and balance,17 social beneﬁts, such as improved
self-conﬁdence, socialization, and a sense of community,17,36
and mental beneﬁts, such as improved mindfulness and
communication.36
The evidence suggested that shared goal setting should be
considered and that the inﬂuence of the caregiver should be
a key factor to be explored during the initiation and imple-
mentation of exercise interventions.20 These recommendations
build on previous work43 to develop a practice pathway for HD
that can inform clinical assessment and intervention planning
that is in line with the Guide to Physical Therapist’s Patient/
Client Management Model (ﬁgure 2).
There may be a beneﬁt for people with HD to receive targeted
exercise interventions multiple times over a year or longer,
rather than relatively short interventions (often 6–8 weeks)
that are abruptly discontinued with minimal follow-up. A
clinical trial is currently underway evaluating this model of
care in individuals with early-mid stage HD.44 There is in-
creasing recognition across neurologic diseases about the
importance of strategies to maintain physical activity through
the life course of the disease32,45–48 Indeed, research across
neurologic conditions provides evidence that secondary pre-
vention strategies are crucial to maintaining function and
warding oﬀ impairments that are secondary to mobility
restrictions.45 Although implementation of inpatient multi-
disciplinary programs, which require extended stays in hos-
pital or rehabilitation centers, is currently not feasible in many
countries, there is supporting evidence to suggest that such
a model should be considered. Importantly, future work must
include economic evaluation and the potential for such pro-
grams to maintain high quality years of living with the disease.
Overall, exercise can be tailored to enable participation by
individuals with HD and to address HD-speciﬁc impairments.
The facilitators for exercise participation identiﬁed by patients
and caregivers included individualized training plans and
schedules, group therapy, cues to improve adherence, and in-
volvement of a committed caregiver or contact person.17,20
Barriers to exercise participation included cognitive impairments,
poor balance, and lack of motivation.17,20 Such barriers may
aﬀect success with rehabilitation; thus, it is important to maxi-
mize facilitators to exercise to ensure success and adherence.
Figure 2 Patient/client management for individuals with Huntington disease using the clinical practice guideline
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The following strategies may assist clinicians in implementing
the guideline statements. Successful translation of this guideline
to practice relies on clinician evaluation of their own practice
environment and clinical skills to determine the best approach
to implement the action statements.
1. Keep a copy of the exercise guidelines for individuals
with HD (provided open access) in a convenient clinic
location
2. Seek training speciﬁc to individuals with HD and
recommended interventions
3. Build relationships with referral sources to encourage early
referral of persons with HD to rehabilitation services
4. Identify a dedicated caregiver or family member to
enhance uptake of exercise in the individual with HD
5. Individualize and tailor exercise training plans to each
individual, using goal setting tools.
The guideline development group will evaluate the uptake of
the guideline, including monitoring of guideline imple-
mentation leading to change in practice at the individual clinic
level and monitoring of endorsements and awareness of the
guideline in the broader HD community.
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